This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Western University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.
Frontiers in immunology · 2021 · senior author
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.
Journal of virology · 2021
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection.
EBioMedicine · 2020
Latest funding
- $3,997,503
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
CIHR · 2017 · Co-investigator
- $100,000
Evaluating the HIV cellular reservoir in preclinical and Phase 1 clinical trial samples after latency reversal with activator vaccines.
CIHR · 2016 · Co-investigator
- $100,000
Eliciting and identifying broad anti-HIV immune response with a Polyvalent Anti-HIV Vaccine
CIHR · 2015 · Nominated PI
18 publications.
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.
Ding C, Patel D, Ma Y, Mann JFS, Wu J, Gao Y
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.
Klein K, Nankya I, Nickel G, Ratcliff AN, Meadows AAJ, Hathaway N, Bailey JA, Stieh DJ, Cheeseman HM, Carias AM, Lobritz MA, Mann JFS, Gao Y, Hope TJ, Shattock RJ, Arts EJ
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection.
Mann JFS, Pankrac J, Klein K, McKay PF, King DFL, Gibson R, Wijewardhana CN, Pawa R, Meyerowitz J, Gao Y, Canaday DH, Avino M, Poon AFY, Foster C, Fidler S, Shattock RJ, Arts EJ
Advances in Developing CAR T-Cell Therapy for HIV Cure.
Qi J, Ding C, Jiang X, Gao Y
Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy.
Siddiqui S, Perez S, Gao Y, Doyle-Meyers L, Foley BT, Li Q, Ling B
Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity.
Paparisto E, Woods MW, Coleman MD, Moghadasi SA, Kochar DS, Tom SK, Kohio HP, Gibson RM, Rohringer TJ, Hunt NR, Di Gravio EJ, Zhang JY, Tian M, Gao Y, Arts EJ, Barr SD
Advances in HIV-1 Vaccine Development.
Gao Y, McKay PF, Mann JFS
Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.
Gao Y, Wijewardhana C, Mann JFS
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system.
Pankrac J, Klein K, McKay PF, King DFL, Bain K, Knapp J, Biru T, Wijewardhana CN, Pawa R, Canaday DH, Gao Y, Fidler S, Shattock RJ, Arts EJ, Mann JFS
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.
Ahmed Y, Tian M, Gao Y
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
Principal investigators: Kobinger, Gary P
Keywords: Cgmp Cell Lines; Enhanced Immunogenicity; Enhanced Production; Hiv Vaccine; Rhesus Macaques; Vsv Vector
Evaluating the HIV cellular reservoir in preclinical and Phase 1 clinical trial samples after latency reversal with activator vaccines.
Principal investigators: Mann, Jamie F
Keywords: Cd4 T Cells; Ctl; Hiv; Latency; Rna; Sequencing; Virus Like Particles
Eliciting and identifying broad anti-HIV immune response with a Polyvalent Anti-HIV Vaccine
Principal investigators: Gao, Yong
Keywords: Antibody; B Cell Maturation; Broad Immune Response; Hiv/Aids; Polyvalent Vaccine; Vaccination Stragtegy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.